Q2FY27 Earnings Call Intimation

October 28, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, 25th Floor, Dalal Street, Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub: Earnings Call Intimation Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, we are enclosing herewith the schedule of Q2 FY 2027 Earnings Call details. This is for your information and records. Yours sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary Encl: As above Neuland Laboratories Limited invites you for its Q2FY27 Earnings Conference Call Details of Earnings Call Date Time November 03, 2026 17:30 Hrs (IST) For registration please click here Webcast Link Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB) For more queries please contact: Neuland Labs IR For over 4 decades, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing ir@neulandlabs.com facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 100 APIs and has filed around 1010+ Regulatory filings in the US (75 active US DMFs), the European Union (EU) and other Runjhun Jain – 98207 20993 geographies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. Runjhun.Jain1@in.ey.com FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI “SID & GP” Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001. Minakshi Machutre – 98671 44505 For more information, visit www.NeulandLabs.com Minakshi.Machutre@in.ey.com